FDA Questions Evidence For Lower-Risk Tobacco Product

WASHINGTON (AP) — U.S. health regulators have questions about the data submitted by tobacco maker Swedish Match in its bid to become the first company to market a smokeless tobacco product as less harmful than cigarettes.

         Food and Drug Administration scientists say they have "concerns" about how the company studied its snus tobacco product and its proposal to modify cancer warning language on the packaging.

         Snus are teabag-like pouches or loose tobacco that users stick between their cheek and gum. They are popular in Scandinavian countries and are part of a growing smokeless tobacco market in the U.S.

- Sponsors -

         The FDA has scheduled a two-day meeting to review company data designed to show that snus do not carry the same risks of mouth cancer, gum disease and tooth loss as other tobacco products.

 

 

- Partner Content -

Entergy’s Energy Smart Program Brings Cost Conscious Innovation to New Orleans

Offering comprehensive energy efficiency at no cost to the consumer, Entergy’s Energy Smart program incentivizes Entergy New Orleans customers to perform energy-saving upgrades in...

 

 

Digital Sponsors / Become a Sponsor

Follow the issues, companies and people that matter most to business in New Orleans.

Email Newsletter

Sign up for our email newsletter